235 related articles for article (PubMed ID: 23856248)
1. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.
Brauer PM; Zheng Y; Wang L; Tyner AL
Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141
[TBL] [Abstract][Full Text] [Related]
4. Vemurafenib Inhibits Active PTK6 in
Wozniak DJ; Hitchinson B; Gilic MB; Bie W; Gaponenko V; Tyner AL
Mol Cancer Ther; 2019 May; 18(5):937-946. PubMed ID: 30926642
[TBL] [Abstract][Full Text] [Related]
5. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract][Full Text] [Related]
6. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.
Zheng Y; Tyner AL
Eur J Clin Invest; 2013 Apr; 43(4):397-404. PubMed ID: 23398121
[TBL] [Abstract][Full Text] [Related]
7. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
8. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
9. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.
Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ
Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321
[TBL] [Abstract][Full Text] [Related]
10. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
[TBL] [Abstract][Full Text] [Related]
13. PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.
Lang YD; Chen HY; Ho CM; Shih JH; Hsu EC; Shen R; Lee YC; Chen JW; Wu CY; Yeh HW; Chen RH; Jou YS
Nat Commun; 2019 Dec; 10(1):5716. PubMed ID: 31844057
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
15. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
Chen ZH; Yu YP; Tao J; Liu S; Tseng G; Nalesnik M; Hamilton R; Bhargava R; Nelson JB; Pennathur A; Monga SP; Luketich JD; Michalopoulos GK; Luo JH
Gastroenterology; 2017 Oct; 153(4):1120-1132.e15. PubMed ID: 28245430
[TBL] [Abstract][Full Text] [Related]
16. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
17. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
18. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
[TBL] [Abstract][Full Text] [Related]
19. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]